Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Electroconvulsive therapy for iatrogenic hypothalamic-hypopituitarism (CRF-ACTH type).

F N Pitts, C W Patterson

    The American Journal of Psychiatry
    |August 1, 1979
    PubMed
    Summary

    Electroconvulsive therapy (ECT) may resolve persistent hypothalamic-pituitary suppression, even without psychiatric disorders. This treatment showed lasting effectiveness in a patient with CRF-ACTH type hypopituitarism.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Induction of anesthesia with methohexital and thiopental in electroconvulsive therapy. The effect on the electrocardiogram and clinical observations in 500 consecutive treatments with each agent.

    The New England journal of medicine·2011
    Same author

    CO(2) laser coincidences with nu(3) of SiF(4) near 9.7 microm.

    Optics letters·2009
    Same author

    CO(2) laser coincidences with nu(3) of SiF(3) near 9.7 microm: errata.

    Optics letters·2009
    Same author

    nu(3) vibrational ladder of SF(6).

    Optics letters·2009
    Same author

    High-resolution double-resonance spectroscopy of 2v(3) ? v(3) transitions in SF(6).

    Optics letters·2009
    Same author

    Spectroscopy of the CF(4) laser.

    Optics letters·2009

    Area of Science:

    • Neuroendocrinology
    • Psychiatry
    • Clinical Medicine

    Background:

    • Hypothalamic-pituitary suppression, specifically CRF-ACTH type, can persist despite discontinuation of exogenous steroids like dexamethasone.
    • Severe chronic depression can be refractory to standard treatments.